Alteogen: Major management decision: Expected receipt of sales milestone from ALT-B4 licensing partner MSD
AI reading
★★★★ Bullish · Material event
Receipt of ALT-B4 sales milestone from MSD
Key figures: Milestone: USD 25,000,000 (approx. ₩34.4bn)
An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).
Other filings by Alteogen
For information only. Not investment advice.